Technical Analysis for IMUC - Immunocellular Thera

Grade Last Price % Change Price Change
grade A 0.0362 0.56% 0.0002
IMUC closed up 0.56 percent on Thursday, October 17, 2019, on 2.34 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical IMUC trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish 0.56%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.56%
NR7 Range Contraction 0.56%
Inside Day Range Contraction 0.56%
Wide Bands Range Expansion 0.56%
20 DMA Support Bullish 0.00%

Older signals for IMUC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.
Medicine Health Biotechnology RTT Cancer Treatment Of Cancer Cancers Immunotherapy Oncology Cancer Immunotherapy Ovarian Cancer Immunotherapies Virotherapy Glioblastoma Brain Tumor Solid Tumor Cancers Northwest Biotherapeutics California Institute Of Technology Glioblastoma Multiforme Steam
Is IMUC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.05
52 Week Low 0.012
Average Volume 132,127
200-Day Moving Average 0.0253
50-Day Moving Average 0.0313
20-Day Moving Average 0.034
10-Day Moving Average 0.0352
Average True Range 0.0078
ADX 17.95
+DI 17.1509
-DI 9.1846
Chandelier Exit (Long, 3 ATRs ) 0.0206
Chandelier Exit (Short, 3 ATRs ) 0.0456
Upper Bollinger Band 0.0399
Lower Bollinger Band 0.0281
Percent B (%b) 0.69
BandWidth 34.705882
MACD Line 0.0012
MACD Signal Line 0.0012
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0488
Resistance 3 (R3) 0.0490 0.0450 0.0467
Resistance 2 (R2) 0.0450 0.0418 0.0449 0.0460
Resistance 1 (R1) 0.0406 0.0398 0.0428 0.0404 0.0453
Pivot Point 0.0366 0.0366 0.0377 0.0365 0.0366
Support 1 (S1) 0.0322 0.0334 0.0344 0.0320 0.0271
Support 2 (S2) 0.0282 0.0314 0.0281 0.0264
Support 3 (S3) 0.0238 0.0282 0.0257
Support 4 (S4) 0.0236